deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03527576

Block Duration After Spinal Block and iv Dexamethasone.

Block Duration After Spinal Block and iv Dexamethasone: a Randomized Controlled Double-blinded Trial

Sponsor: Eric Albrecht

Updated 8 times since 2018 Last updated: Jul 19, 2022 Started: May 1, 2018 Primary completion: Nov 1, 2021 Completion: Apr 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03527576, this PHASE4 trial focuses on Lower Limb Injury and Postoperative Pain and remains completed. Sponsored by Eric Albrecht, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotRecruiting~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotRecruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotRecruiting~Feb 2021 – ~Apr 2022 · 14 months · monthly snapshotRecruiting~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Sep 2022 — Jul 2024 [monthly]

    Completed PHASE4

    Status: RecruitingCompleted

  4. Apr 2022 — Sep 2022 [monthly]

    Recruiting PHASE4

  5. Feb 2021 — Apr 2022 [monthly]

    Recruiting PHASE4

Show 3 earlier versions
  1. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE4

  2. Aug 2019 — Jan 2021 [monthly]

    Recruiting PHASE4

  3. Jun 2018 — Aug 2019 [monthly]

    Recruiting PHASE4

    First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eric Albrecht
Data source: Centre Hospitalier Universitaire Vaudois

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations